Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer
-
ACMG Comments to CMS Concerning CLFS Gapfill Preliminary Determinations for GS Codes 81425, 81426, and 81427
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
ACMG Comments to CMS on Proposed NCD for Coverage of NGS for Medicare Beneficiaries with Advanced Cancer (CAG-00450N)
-
ACMG Testimony in Support of the Accurate Education for Prenatal Screenings Act (HR 3441)
-
ACMG Letter to Congress Supporting the Accurate Education for Prenatal Screenings Act (HR 3441)